NewslettersDermal Cell NewsUncategorizedTofacitinib and Metformin Reduce the Dermal Thickness and Fibrosis in Mouse Model of Systemic SclerosisBy Justin.choi - February 16, 202208Researchers investigated the therapeutic efficacy of tofacitinib and metformin on IL-17 and transforming growth factor beta cytokines, skin fibrosis and inflammation in mouse model of systemic sclerosis.[Scientific Reports] 6445212 AAAAAAAA items 1 apa 0 default asc 1 171921 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article